Doxazosin and Carvedilol Treatment Improves Hepatic Regeneration in a Hamster Model of Cirrhosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxazosin and Carvedilol Treatment Improves Hepatic Regeneration in a Hamster Model of Cirrhosis
Authors
Keywords
-
Journal
Biomed Research International
Volume 2018, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2018-12-13
DOI
10.1155/2018/4706976
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A case of rapid recurrence of apocrine ductal carcinoma originating from the oral scent gland of a Richardson’s ground squirrel (Urocitellus richardsonii)
- (2018) Ayumi EGUCHI et al. Journal of Toxicologic Pathology
- Adenoviral-bone morphogenetic protein-7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model
- (2017) Daniel Cervantes-Garcia et al. Molecular Medicine Reports
- Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation
- (2017) Xiaopeng Tian et al. Biomed Research International
- Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion
- (2016) Martin Humberto Muñoz-Ortega et al. Gut and Liver
- Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation
- (2015) Simone Carotti et al. JOURNAL OF CLINICAL PATHOLOGY
- Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome
- (2014) Sonya Parpart et al. HEPATOLOGY
- TGF-β secreted from activated hepatic stellate cells may induce the transdifferentiation of hepatocytes into hepatocarcinoma in HBx-expressing livers
- (2014) Manh Tin Ho et al. Journal of the Korean Society for Applied Biological Chemistry
- Liver cirrhosis
- (2014) Emmanuel A Tsochatzis et al. LANCET
- Liver regeneration
- (2014) Shennen A. Mao et al. Translational Research
- Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis
- (2013) Yulia A. Nevzorova et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Allopurinol Reverses Liver Damage Induced by Chronic Carbon Tetrachloride Treatment by Decreasing Oxidative Stress, TGF-� Production and NF-κB Nuclear Translocation
- (2013) Liseth R. Aldaba-Muruato et al. PHARMACOLOGY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage
- (2012) Nadia Hamdy et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Distribution of Hepatic Myofibroblasts and Type I and III Collagen in Rat Liver Cirrhosis Induced by Thioacetamide
- (2011) Raksawan Poonkhum et al. INTERNATIONAL JOURNAL OF MORPHOLOGY
- Liver Regeneration after Partial Hepatectomy
- (2009) George K. Michalopoulos AMERICAN JOURNAL OF PATHOLOGY
- Immune Interactions in Hepatic Fibrosis
- (2008) Andrew P. Holt et al. Clinics in Liver Disease
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started